Although human pedigrees carrying the ryanodine receptor type 1 (RyR1) mutations mainly show skeletal muscle disorders including malignant hyperthermia (MH), sudden cardiac death (SCD) in these MH families in the conscious condition without anesthesia are also frequently found in the clinical case studies. However, the molecular mechanism underlying cardiac phenotypes in human MH family is completely unknown. Our group previously reported that a low level of RyR1 is expressed in the mitochondria, but not in the sarcoplasmic reticulum (SR) in the rat and mouse hearts, which serves as an important mitochondrial Ca2+ influx pathway in addition to the mitochondrial Ca2+ uniporter in cardiomyocytes. We also showed, using knock‐in mice carrying a MH‐related RyR1 mutation Y522S (YS) that YS hearts exhibit disrupted mitochondrial morphology as well as compromised mitochondrial functions with a high cellular oxidative state. Moreover, ex‐vivo YS heart developed significantly higher number of multiple ventricular extrasystoles by β‐adrenergic stimulation compared those observed in the wild‐type (WT) hearts. Therefore, our main hypothesis is that YS‐RyR1s form “leaky channel” at mitochondria and induce mitochondrial Ca2+ overload, which alters the cellular Ca2+ handing in cardiomyocyte. Using isolated mitochondria loaded with Ca2+ or membrane‐potential sensitive dyes under the confocal microscope, we found that YS mitochondria have higher basal mitochondrial Ca2+ concentration, depolarized mitochondrial membrane potential. In addition, YS cardiomyocytes exhibit higher basal cytosolic Ca2+ concentration as well as slower cytosolic Ca2+ clearance compared to WT. Finally, pretreatment of RyR1 blocker dantrolene cancelled these changes in YS mitochondria and cardiomyocyes and normalized their Ca2+ handing profiles similar to those in WT. In summary, these results indicate that chronic mitochondrial Ca2+ overload via leaky mutant mRyR1 damages cardiac mitochondrial functions/structures, which may alter cytosolic Ca2+ handling, induce cellular oxidation, and increase the arrhythmogenic events in MH.Support or Funding Information16SDG27260248 AHA Scientist Development Grant